What is the most likely diagnosis and recommended initial work‑up for a patient with low blood urea nitrogen, low creatinine, a high albumin‑to‑globulin ratio, and an isolated elevation of alanine aminotransferase?

Diagnostic Approach to Low BUN, Low Creatinine, High Albumin/Globulin Ratio, and Elevated ALT

The most likely diagnosis is early hepatocellular liver injury, with nonalcoholic fatty liver disease (NAFLD) being the primary consideration, though the low BUN and creatinine suggest either low muscle mass, malnutrition, or dilutional states that require further evaluation. 1

Initial Diagnostic Framework

Understanding the Laboratory Pattern

This constellation represents a hepatocellular pattern of injury with confounding nutritional or metabolic factors:

• Elevated ALT indicates hepatocyte injury and is the most specific marker for liver disease, with normal ranges being 29-33 IU/L in men and 19-25 IU/L in women 1
• Low BUN and creatinine together typically indicate decreased protein intake, low muscle mass, overhydration, or severe liver disease affecting urea synthesis (though the latter usually presents with other signs of hepatic dysfunction) 1
• High albumin/globulin ratio suggests preserved hepatic synthetic function with relatively low globulins, making chronic inflammatory conditions, cirrhosis, or autoimmune hepatitis less likely 1

Severity Classification

The degree of ALT elevation determines urgency 1:

• Mild elevation: <5 times upper reference limit
• Moderate elevation: 5-10 times upper reference limit
• Severe elevation: >10 times upper reference limit

Recommended Initial Work-Up

First-Line Laboratory Testing

Obtain a comprehensive liver aetiology screen immediately 1:

• Viral hepatitis panel: Hepatitis B surface antigen, hepatitis C antibody with reflex PCR if positive 1
• Autoimmune markers: Anti-mitochondrial antibody, anti-smooth muscle antibody, antinuclear antibody, serum immunoglobulins 1
• Metabolic screening: Simultaneous serum ferritin and transferrin saturation (for hemochromatosis) 1
• Complete metabolic panel: AST, alkaline phosphatase, GGT, total bilirubin, total protein, albumin, and globulin levels to calculate the R-value 1
• Fasting lipid panel and glucose/HbA1c: To assess for metabolic syndrome components associated with NAFLD 1

Calculate the R-Value

The R-value determines injury pattern 1:

• R = (ALT/ALT upper limit) ÷ (ALP/ALP upper limit)
• R ≥ 5: Hepatocellular injury (most consistent with your presentation)
• R = 2-5: Mixed injury
• R ≤ 2: Cholestatic injury

First-Line Imaging

Abdominal ultrasound is the appropriate initial imaging study 1:

• Sensitivity of 84.8% and specificity of 93.6% for moderate-to-severe hepatic steatosis (>30% fat content) 1
• Evaluates for hepatomegaly, cirrhosis features, biliary obstruction, and vascular patency 1
• Cost-effective and noninvasive screening tool 1

Critical caveat: Ultrasound sensitivity drops to 53-65% for mild steatosis and is further limited by obesity, inflammation, or fibrosis 1

Differential Diagnosis Priority

Most Likely: Nonalcoholic Fatty Liver Disease

NAFLD is the most common liver disease in developed countries, affecting 20-30% of the general population 1:

• Prevalence increases to 70% with obesity and 90% with diabetes 1
• Typically presents with AST:ALT ratio <1 (versus >2 in alcoholic liver disease) 1
• Associated with insulin resistance and metabolic syndrome 1

If NAFLD is confirmed, perform risk stratification for fibrosis 1:

• First-line: Calculate FIB-4 score or NAFLD Fibrosis Score (NFS)
• These noninvasive scores determine need for advanced imaging or liver biopsy

Alternative Diagnoses to Exclude

Drug-induced liver injury (DILI) 1:

• Review all medications, supplements, and herbal products
• Common culprits include antimicrobials, antiepileptics, statins, and acetaminophen
• Check acetaminophen level if any suspicion of toxicity 1

Viral hepatitis 1:

• Hepatitis A, B, C can present with isolated ALT elevation
• Acute hepatitis C may be anti-HCV negative but HCV RNA positive 1

Autoimmune hepatitis 1:

• Critical distinction: Low titers of autoantibodies can occur in NAFLD, but high titers with elevated globulins or high total protein-to-albumin ratio mandate liver biopsy 1
• More common in children but can present at any age

Wilson disease (especially if patient <40 years) 1:

• Check serum ceruloplasmin and copper levels
• Consider slit-lamp examination for Kayser-Fleischer rings
• AST may exceed ALT, with alkaline phosphatase:bilirubin ratio <2 in fulminant presentations 1

Hemochromatosis 1:

• Elevated ferritin and transferrin saturation
• Genetic testing if iron studies abnormal

Special Considerations for Low BUN/Creatinine

The combination of low BUN and low creatinine is unusual and requires specific attention:

• Assess nutritional status: Low protein intake, malnutrition, or eating disorders can cause low BUN
• Evaluate muscle mass: Sarcopenia, cachexia, or neuromuscular disorders lower creatinine production
• Consider overhydration: SIADH or excessive fluid intake dilutes both markers
• Severe liver disease: Advanced cirrhosis impairs urea synthesis, but this contradicts the high albumin/globulin ratio in your case

Do not use BUN or creatinine alone to assess renal function in this context—calculate estimated GFR and consider cystatin C if renal function assessment is critical 1

When to Perform Liver Biopsy

Liver biopsy is indicated when 1:

• Diagnosis remains uncertain after initial work-up
• Multiple potential etiologies are present
• High autoantibody titers with elevated globulins suggest autoimmune hepatitis 1
• Before initiating potentially hepatotoxic pharmacological therapy 1
• Noninvasive fibrosis scores suggest advanced disease requiring staging 1

Common Pitfalls to Avoid

• Do not assume normal liver function based on preserved albumin alone—early NAFLD and NASH can have normal synthetic function 1
• Do not overlook medication/supplement history—herbal products and over-the-counter drugs are frequent causes of hepatotoxicity 1
• Do not dismiss mild ALT elevations—updated healthy ranges are lower than traditional cutoffs (men: 30 U/L; women: 19 U/L), and mild elevations can indicate significant disease 2
• Do not order AST routinely with ALT—AST adds limited value in most cases and increases unnecessary costs 3
• Do not rely on AST:ALT ratio alone—while suggestive, it lacks sufficient sensitivity and specificity for definitive diagnosis 1